時間 | 主題 | ||||
---|---|---|---|---|---|
13:30 ~ 13:35 |
Opening
講者:
李建儀
|
李建儀 |
|||
Comparative study between behavior therapy and behavior therapy plus mirabegron 50mg in sexually active men with bothersome OAB symptoms – A multicenter, randomized study
講者:
林志杰
座長:
闕士傑, 莊燿吉 |
林志杰 |
闕士傑, 莊燿吉 |
|||
Mirabegron is more tolerable than solifenacin in Sjogren’s syndrome patients with OAB symptoms
講者:
曾浩翔
座長:
鄒頡龍, 莊斐琪 |
曾浩翔 |
鄒頡龍, 莊斐琪 |
|||
Drug Utilization Patterns in Patients with Lower Urinary Tract Dysfunctions (LUTD) in Taiwan
講者:
柳瑞明
座長:
鍾旭東, 陳崇鈺 |
柳瑞明 |
鍾旭東, 陳崇鈺 |
|||
Urine Biomarkers in LUTD
講者:
江元宏
座長:
郭漢崇, 王炯珵 |
江元宏 |
郭漢崇, 王炯珵 |
|||
The effect of 2-carba-cyclic phosphatidic acid on treatment chronic cystitis rats
講者:
陳進利
座長:
李偉嘉, 蒙恩 |
陳進利 |
李偉嘉, 蒙恩 |
|||
15:40 ~ 16:00 |
Break |
||||
Comparison of Thulium Laser Enucleation and conventional transurethral resection among BPH patients
講者:
謝博彥
座長:
蔡曜州, 林友翔 |
謝博彥 |
蔡曜州, 林友翔 |
|||
Risk factors associated with prostate abscess management and outcome
講者:
楊立宇
座長:
林威宇, 許毓昭 |
楊立宇 |
林威宇, 許毓昭 |
|||
Prostate cancer risk during BPH medical treatment
講者:
李思恩
座長:
阮雍順, 林子平 |
李思恩 |
阮雍順, 林子平 |
|||
Outcome analysis after transurethral resection of prostate
講者:
陳思如
座長:
吳俊賢, 余宏政 |
陳思如 |
吳俊賢, 余宏政 |
|||
17:40 ~ 18:00 |
Closing
講者:
廖俊厚
|
廖俊厚 |